Every four years at the Cybathlon, teams of researchers and technology “pilots” compete to see whose brain-computer interface ...

Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.

Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...

A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

Synchron successfully implanted the first FDA-approved brain-computer interface in a U.S. patient with ALS. The device ...

The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development of a next-generation interface.

Paradromics announced that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer interface (BCI).

Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments.

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

Partnership between Boomi and DXC an example of where support can be offered to build the foundations of an effective agentic ...

In this system, the implanted computer chip would not just sit on the brain, but become part of the brain. Using a technology ...

“The Bee Sting” by Paul Murray. The plot builds slowly to a breathtaking crescendo. But the real genius is in how it’s told: ...